BioPharma Credit PLC (OTCMKTS:BOPCF) Short Interest Up 1,714.1% in August

BioPharma Credit PLC (OTCMKTS:BOPCF) was the recipient of a large increase in short interest during the month of August. As of August 31st, there was short interest totaling 32,491 shares, an increase of 1,714.1% from the August 15th total of 1,791 shares. Based on an average daily volume of 25,555 shares, the days-to-cover ratio is presently 1.3 days.

BioPharma Credit Stock Performance

OTCMKTS:BOPCF remained flat at $0.93 during midday trading on Thursday. The company had a trading volume of 21,488 shares, compared to its average volume of 337,758. The firm has a 50-day moving average price of $0.96 and a two-hundred day moving average price of $0.94. BioPharma Credit has a one year low of $0.85 and a one year high of $1.02.

BioPharma Credit Company Profile

BioPharma Credit (OTCMKTS: BOPCF) is a closed-end investment company that specializes in providing debt financing solutions to the global life sciences sector. The firm offers a range of credit products—including senior secured loans, convertible loans and royalty monetization structures—designed to meet the capital needs of biotechnology and pharmaceutical companies across pre-clinical, clinical and commercial stages. By focusing on secured and structured credit, BioPharma Credit seeks to deliver consistent income while managing risk through collateralized arrangements and diversified portfolios.

Since its inception in 2016, the company has built a track record of partnering with innovative drug developers and medical technology firms.